- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06382194
Decision Making Tool for Firearm Storage
April 6, 2026 updated by: Elizabeth Phelan, University of Washington
Shared Decision Making for Firearm Safety Among Older Adults With Early Changes Associated With Alzheimer's Disease/Alzheimer's Disease-Related Dementias (AD/ADRD)
This is a one-arm pilot study testing the feasibility and acceptability of a decision aid about safe firearm storage.
Study Overview
Detailed Description
This pilot study will test the feasibility and acceptability of a decision aid about safe firearm storage with firearm-owning persons with early dementia and/or depression
Study Type
Interventional
Enrollment (Actual)
5
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Washington
-
Seattle, Washington, United States, 98104
- University of Washington
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Medical record documentation of early dementia and/or depression
- Internet or mobile device access
- Access to firearm(s)
Exclusion Criteria:
• Active suicidality
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention Arm
Participants in this arm will receive the intervention and undergo research assessments.
|
The intervention is a newly developed decision aid designed to guide decisions about storage of firearms among older gun owners with early dementia and/or depression.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Participants With Any Improvement in Safe Firearm Storage (Adapted From the National Firearm Survey)
Time Frame: Assessed at 4 weeks post enrollment
|
Data were reported on an ordinal scale (0=unlocked and loaded; 1=unlocked and unloaded; 2=locked and loaded; 3=locked and unloaded; 4=removed from house).
Any improvement on the ordinal scale from baseline to follow-up was dichotomized (0=no improvement; 1=any improvement in safe firearm storage).
|
Assessed at 4 weeks post enrollment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change From Baseline in the Low-Literacy Decisional Conflict Scale Score
Time Frame: Assessed at 4 weeks post enrollment
|
Measured by the Low Literacy Decisional Conflict Scale.
This is a 10-item scale.
Response options for each item are yes (0), no (4), unsure (2).
Score range is from 0 (no decisional conflict) to 40 (extremely high decisional conflict).
Lower scores represent a better outcome.
|
Assessed at 4 weeks post enrollment
|
|
Change From Baseline in Firearm Safe Storage Knowledge Questionnaire Score
Time Frame: Assessed at 4 weeks post enrollment
|
A measure of participant understanding of firearm safe storage, alternatives, rationale, risks and benefits.
Each questionnaire item is given a score value of 1 (if participant correctly selects 'true' or 'false') or zero (if participant selects the incorrect answer or selects 'unsure').
Item values are totaled to obtain an overall knowledge score.
Minimum score is 0 and maximum score is 8, with higher scores representing a better outcome.
|
Assessed at 4 weeks post enrollment
|
|
Number of Participants Who Access the Intervention
Time Frame: Assessed at 4 weeks post enrollment
|
Number of participants who access and report watching the decision aid intervention at follow-up
|
Assessed at 4 weeks post enrollment
|
|
Mean Score on the Acceptability of Intervention Measure
Time Frame: Assessed at 4 weeks post enrollment
|
A 4-item measure of the intervention's acceptability from the perspective of the participants, assessed at follow-up.
The response option for each item is a 5-point Likert scale, ranging from 1 (completely disagree) to 5 (completely agree).
The score for the scale is calculated as the average of responses on the 4 items.
The minimum score on the scale is 1, and the maximum score is 5. Higher scores represent a better outcome.
|
Assessed at 4 weeks post enrollment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Elizabeth Phelan, University of Washington
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 10, 2024
Primary Completion (Actual)
October 9, 2024
Study Completion (Actual)
October 9, 2024
Study Registration Dates
First Submitted
April 2, 2024
First Submitted That Met QC Criteria
April 19, 2024
First Posted (Actual)
April 24, 2024
Study Record Updates
Last Update Posted (Actual)
April 28, 2026
Last Update Submitted That Met QC Criteria
April 6, 2026
Last Verified
April 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Mental Disorders
- Neoplasms
- Immune System Diseases
- Behavioral Symptoms
- Neoplasms by Histologic Type
- Neurocognitive Disorders
- Lymphatic Diseases
- Lymphoproliferative Disorders
- Immunoproliferative Disorders
- Lymphoma, Non-Hodgkin
- Lymphoma
- Behavior
- Hemic and Lymphatic Diseases
- Depression
- Lymphoma, Follicular
- Dementia
- Investigative Techniques
- Decision Support Techniques
Other Study ID Numbers
- STUDY00014522
- 1R21AG076362-01 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
Massachusetts General HospitalRecruitingDepression | Depression - Major Depressive Disorder | Depression Chronic | Depression in Adults | Depression Disorders | Depression DisorderUnited States
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Active, not recruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
ProgenaBiomeWithdrawnDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Sorlandet Hospital HFUniversity of Oslo; Karolinska Institutet; Australian Catholic University; Helse...RecruitingAnxiety | Anxiety Depression | Depression Anxiety Disorder | Depression - Major Depressive DisorderNorway
-
Lipocine Inc.CompletedDepression, Postpartum | Postnatal Depression | Peripartum Depression | Depression, Post-Partum | Postpartum Depression (PPD) | Post-Natal DepressionUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryActive, not recruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Kolby Walker, DO; Brittany KimbleRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of CincinnatiNational Center for Complementary and Integrative Health (NCCIH)RecruitingMild DepressionUnited States
-
University of MinnesotaCompletedDepression SymptomsUnited States
Clinical Trials on Decision aid
-
University of LeedsBaxter Healthcare Corporation; National Health Service, United Kingdom; Foundation... and other collaboratorsCompletedChronic Kidney FailureUnited Kingdom
-
Massachusetts General HospitalCompletedCoronary Artery Disease | Stable AnginaUnited States
-
University Hospital HeidelbergInnovationsfonds des Gemeinsamen Bundesausschusses, GermanyCompletedPatient Decision Aid | Treatment As UsualGermany
-
Case Comprehensive Cancer CenterCompletedProstate CancerUnited States
-
Duke UniversityFoundation for Informed Medical Decision MakingCompletedOsteoarthritisUnited States
-
Massachusetts General HospitalUnknownDecision Making | Video Decision AidsUnited States
-
Kaiser PermanenteFoundation for Informed Medical Decision MakingCompletedObesity | Obesity, Morbid | Bariatric Surgery | Decision AidsUnited States
-
University of UtahPatient-Centered Outcomes Research Institute; Mayo Clinic; Northwestern University and other collaboratorsCompletedAtrial FibrillationUnited States
-
University of MichiganNational Cancer Institute (NCI)Completed
-
Massachusetts General HospitalCompleted